• Medical_Professionals
• Medical_students
• Nurses

The Global Cardio-Oncology Summit 2017 is co-hosted the British Cardio-Oncology Society and the British Cardiovascular Society. This year’s summit will be co-chaired by Dr. Alexander Lyon, BHF Senior Lecturer and Honorary Consultant Cardiologist at the Royal Brompton Hospital, and Dr. Susannah Stanway, Consultant Medical Oncologist at the Royal Marsden Hospital, in London, UK.

This summit models a leading-edge interdisciplinary approach to preventative and targeted medicine in cardio-oncology. This important field of study, aimed at understanding cardiac complications of oncology treatments, has gained a growing interest from a number of healthcare providers including oncologists, cardiologists, radiologists, nurses, pharmacists, and basic scientists.

The Global Cardio-Oncology Summit will feature the latest research and clinical guidelines in the multidisciplinary field of cardio-oncology. We invite abstract submissions for the Global Cardio-Oncology Summit on the prevention, management and treatment of cardiac complications related to oncology therapy.

Registration now open!

For more information, please contact info@cardiaconcology.ca.

We look forward to meeting with you in September 2017!

Dr. Alexander Lyon                                                      Dr. Susannah Stanway

Co-Chair, GCOS 2017                                                    Co-Chair, GCOS 2017

Honorary Consultant Cardiologist                              Consultant Medical Oncologist

Royal Brompton Hospital                                             Royal Marsden Hospital

London, United Kingdom                                             London, United Kingdom

Dr. Laleh Amiri-Kordestani, MD

Medical Officer, Division of Oncology Products 1, Food and Drug Administration, Centre for Drug Evaluation and Research, Silver Spring, MD, USA

founder

Laleh Amiri-Kordestani, M.D. is a clinical team leader and cardio-oncology liaison at the FDA, CDER, Office of Hematology and Oncology Products. At the FDA, Dr. Amiri has focused on cardio-oncology and breast cancer oncology drug development. Dr. Amiri attended the University of Tehran Medical Sciences.

Co-Chair: Session 7 - Cardio-Oncology & Heamato-Oncology

Dr. Ana Barac, MD, PhD, FACC

Staff Cardiologist, MedStar Heart and Vascular Institute; Associate Professor of Medicine and Oncology, Georgetown University, Washington, DC, USA

founder

Ana Barac, MD, PhD, is a staff cardiologist at MedStar Heart and Vascular Institute and an Associate Professor of Medicine and Oncology at Georgetown University. Her clinical and research interests focus on the mechanisms, diagnosis and treatment of cardiovascular disease in patients undergoing cancer treatment and she leads MedStar’s Cardio-Oncology program. Dr. Barac’ clinical expertise is in cardiac magnetic resonance and echocardiography. 

Co-Chair: Session 5 - Coordinating Primary Care in Cardio-Oncology

Dr. Anne Blaes, MD, MS

Associate Professor, Division of Hematology, Oncology and Transplantation, Program Director, Adult Cancer Survivor Program, University of Minnesota, Minneapolis, MN, USA

founder

Dr. Anne Blaes is an associate professor in the Division of Hematology, Oncology and Transplantation at the University of Minnesota and a member of the Masonic Cancer Center. She is a graduate from the University of Notre Dame and Loyola University Chicago, Stritch School of Medicine. She completed her residency, chief residency and fellowship, and a masters in clinical research at the University of Minnesota prior to joining the faculty where she has received numerous teaching awards including The Gold Foundation Humanism and Excellence in Teaching Award, an Educational Excellence Award, and an Outstanding Clinical Educator awards. 

Conference Topic: Session 3 - Novel pathophysiology of cardiovascular risk with estrogen antagonists

Prof. Jutta Bergler-Klein, MD, FESC

Professor of Medicine and Cardiology; Head of Cardiac Outpatients and Acute first care unit; Vice Head, Day Clinic; Senior Consultant Cardiology Dept. of Cardiology, University Clinic of Internal Med. II, Medical University of Vienna, AKH General Hospital, Vienna, Austria

founder

At the Medical University of Vienna, Prof. Jutta Bergler-Klein heads the cardiac outpatient clinic. She is currently chair of the Echo Working Group of the Austrian Society of Cardiology and involved in the European EACVI, and fellow of the ESC. Special research interests are valve disease, biomarkers and cardio-oncology.

Conference Topic: Session 4 - Case Review

Dr. Daniela Cardinale, MD, PhD

Cardioncology Unit Director, European Institute of Oncology, Milan, Italy

founder

Dr. Daniela Cardinale graduated from the University of Milan in 1987 and specialized in Cardiology (Milan 1992). She holds a PhD in Cardiovascular Physiopathology from the same University (2009). She is currently Director of the Cardioncology Unit of the European Institute of Oncology in Milan, where she has been working since 1994.

Co-Chair: Session 6 - Young Investigator Competition

Dr. John-Paul Carpenter, MBBS, BSc(Hons), FRCP(UK), MD(Res)

Consultant Cardiologist and Clinical Lead for Cardiology, Poole Hospital NHS Foundation Trust, Poole, Dorset, United Kingdom

founder

Dr Carpenter is a Cardiologist and Clinical Lead for Cardiology at Poole Hospital with a specialist interest in cardio-oncology and cardiovascular imaging. He qualified in 1996 from Guy's and St. Thomas' Hospitals before training in Cardiology. He was appointed to a National Institutes of Health (NIH) funded research Fellowship at the Royal Brompton Hospital in London in 2007, followed by a Clinical Fellowship in imaging and heart failure at University Hospitals Southampton before taking up a locum consultant position in cardiovascular MRI, inherited cardiac diseases and cardio-oncology at the Brompton where he assisted Dr Alex Lyon in setting up the specialist cardio-oncology service. 

Co-Chair: Session 9 - Arrhythmia management in cancer patients

Vicki Chambers, BSc(Hons), RGN

Heart Failure Clinical Nurse Specialist, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom

Vicki qualified as a nurse in 1991 as a direct entry graduate from the University of Surrey with a BSc(Hons) in Nursing Studies. She worked for 2 years in acute medicine and then took up a post in a London cardiac tertiary centre where she gained her cardiac nursing qualifications. She has been a cardiac nurse specialist for 24yrs and worked in primary, secondary and tertiary care. She has worked as a project manager and a nurse manager.

Conference Topic: Session 10 - The Role of the Clinical Nurse Specialist in Cardio-Oncology

Dr. Sarah Clarke, MA, MD, FRCP, FESC, FACC

Consultant Cardiologist, Papworth Hospital, Cambridge, United Kingdom. President, British Cardiovascular Society.

founder

Dr Sarah Clarke MA MD FRCP FESC FACC, is a Consultant Cardiologist at Papworth Hospital, Cambridge and was elected President of the British Cardiovascular Society (BCS) in 2014, taking up office in June 2015 for a 3 year term. Dr Clarke trained in Cambridge and at the Massachusetts General Hospital in Boston, USA. She was appointed Consultant Cardiologist (Interventional Cardiology) at Papworth Hospital, Cambridge in 2002. 

Co-Chair: Session 1

Dr. Sinead Clarke, MB.CHB. Dip Pall Med. MRCGP.

GP Advisor, Macmillan Cancer Support; General Practitioner, Nantwich, United Kingdom

founder

Sinead is a GP working in Nantwich Cheshire and has worked for Macmillan, first as a Macmillan GP and more recently as a GP Advisor for a number of years. She has had a career long interest in Cancer and leads on living with and beyond cancer for Macmillan and is also working as part of the team focussing on treatable but incurable cancers. When not working or acting as a taxi service for her son she enjoys swimming, hiking and reading science fiction novels.

Conference Topic: Session 5 - Raising Awareness of cardiotoxicity in primary care

Prof. Jane Dacre, MD, PRCP

President, Royal College of Physicians, London, UK

founder

Professor Jane Dacre was elected president of the Royal College of Physicians in April 2014. She is an honorary consultant physician and rheumatologist at the Whittington hospital in North London, Professor of Medical Education and was Director of UCL Medical School in London before taking a secondment to become PRCP. Professor Dacre was also the medical director of MRCPUK until December 2013 and prior to that academic vice president of the RCP.

Conference Topic: Day 2 - Opening Address

Prof. Sarah Darby, PhD

Professor of Medicine Statistics, Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, England

founder

Sarah C Darby is Professor of Medical Statistics in the University of Oxford.  She studies Mathematics for her undergraduate degree, followed by a PhD in Medical Statistics at the London School of Hygiene and Tropical Medicine. After graduating, she worked at St. Thomas’ Hospital Medical School, the National Radiological Protection Board, and the Radiation Effects Research Foundation in Hiroshima before moving to the University of Oxford in 1984.  

Conference Topic: Session 4 - Radiation-related heart disease: where are we now?

Dr. Susan Dent, MD, FRCPC

President, Canadian Cardiac Oncology Network; Professor, Department of Medicine, University of Ottawa; Medical Oncologist, The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada

founder

Dr. Dent is a Medical Oncologist at The Ottawa Hospital Cancer Centre and Professor in the Department of Medicine at the University of Ottawa.  She obtained her MD at McMaster University and completed her postgraduate training in Internal Medicine at the University of Ottawa. She continued her training in Medical Oncology in Ottawa, followed by a fellowship year in Clinical Research with the National Cancer Institute of Canada Clinical Trials Group. 

Co-Chair: Session 1

Dr. Martin Denvir

Consultant Cardiologist, University of Edinburgh, Edinburgh, UK

Conference Topic: Session 4 - How to treat radiation-induced coronary disease? Prevention & Treatment

GBP

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Hotel Reservations Limited

Hotel Reservations Limited has negotiated corporate rates with tried and tested quality hotels in close proximity to the Royal College of Physicians. 

This site allows you to check:

-Book safely and securely 24/7 online via the internet

-Gain major discounts over the Hotel’s published rates

-Discounted Weekend rates should you wish to extend your stay or arrive Sunday night

Online Reservations: https://hotelreservations.vbookings.co.uk 

Submission Info

Call for Science: Monday, March 20, 2017

Abstract Submission Deadline: Wednesday, May 31, 2017 at 11:59 GMT

Abstract Notification Letters: Friday, June 30, 2017

Abstract submission deadline 2017-07-02

The 2017 GCOS Young Investigator Award recognizes outstanding research achievements by a young investigator at the early stage of their career in the field of cardio-oncology. Three candidates will be selected to give an oral presentation during the Young Investigator Competition on September 20, 2017.

Please see attached abstract form for detailed eligibility criteria and nomination material for submission.

CCON

Phone: 613-722-7000

Email: info@cardiaconcology.ca

PLATINUM SPONSOR

GOLD SPONSOR

SILVER SPONSOR

BRONZE SPONSORS

CCON

Phone: 613-722-7000

Email: info@cardiaconcology.ca